·
2 MIN READ

AMA applauds FDA for approving naloxone product to prevent overdoses

The AMA praises the FDA for approving the nasal spray version of naloxone, a medication that can reverse effects of an opioid overdose by restoring breathing.

Press Releases
·
3 MIN READ

As opioid use disorders increase, physicians offer solutions

As the opioid epidemic remains a devastating issue for patients and their families, a study published Tuesday in JAMA highlights the need to enhance access to treatment to curb the rising toll opioid use disorders are taking on the country.

Overdose Epidemic
·
4 MIN READ

It's about saving lives: Increasing access to naloxone

Increased access to naloxone, prescription drug monitoring programs, and enhanced education are among the tools physicians must regularly use available to fight the prescription opioid and heroin overdose epidemic our nationa faces. It’s about saving lives.

series
Leadership
Leadership Viewpoints
·
2 MIN READ

Prevent opioid overdose: CME module explains how

Learn how to prevent opioid overdose through patient education and the overdose reversal drug naloxone by participating in a free continuing medical education (CME) online activity.

Overdose Epidemic
·
3 MIN READ

New FDA approval expected to reduce opioid overdose deaths

Approval granted Thursday by the U.S. Food and Drug Administration (FDA) for a user-friendly opioid overdose antidote could help curb the growing public health crisis of U.S. overdose deaths.

Overdose Epidemic
·
3 MIN READ

State, federal bills take on opioid overdose deaths with reversal drug

Legislation to increase access to the opioid overdose reversal drug naloxone is moving forward around the country, on the heels of Attorney General Eric Holder’s recent recommendations that first responders should carry the antidote with them.

Overdose Epidemic